生物活性 | |||
---|---|---|---|
描述 | SZL P1-41, a specific inhibitor of Skp2, attaches to the F-box domain of Skp2, inhibiting the association with Skp1 and the formation of the Skp2 SCF complex. Similar to the effects of Skp2 deficiency, SZL P1-41 enhances apoptosis/senescence mediated by p27 and disrupts glycolysis driven by Akt. It exhibits anti-tumor activities. At concentrations ranging from 5 to 20μM over a period of 24 hours, it leads to the induction of endogenous p27 protein expression in PC3 cells. Additionally, it prompts the expression of p21, another substrate of Skp2.[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.89mL 2.38mL 1.19mL |
23.78mL 4.76mL 2.38mL |
参考文献 |
---|